Logo image of USA.CA

AMERICAS GOLD AND SILVER COR (USA.CA) Stock Fundamental Analysis

TSX:USA - Toronto Stock Exchange - CA03062D1006 - Common Stock - Currency: CAD

1.27  +0.01 (+0.79%)

Fundamental Rating

2

Taking everything into account, USA scores 2 out of 10 in our fundamental rating. USA was compared to 797 industry peers in the Metals & Mining industry. Both the profitability and financial health of USA have multiple concerns. While showing a medium growth rate, USA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year USA has reported negative net income.
In the past year USA has reported a negative cash flow from operations.
USA had negative earnings in each of the past 5 years.
USA had a negative operating cash flow in each of the past 5 years.
USA.CA Yearly Net Income VS EBIT VS OCF VS FCFUSA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -26.81%, USA is in line with its industry, outperforming 44.54% of the companies in the same industry.
The Return On Equity of USA (-89.16%) is worse than 64.76% of its industry peers.
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USA.CA Yearly ROA, ROE, ROICUSA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 19.23%, USA belongs to the top of the industry, outperforming 87.47% of the companies in the same industry.
In the last couple of years the Gross Margin of USA has grown nicely.
USA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USA.CA Yearly Profit, Operating, Gross MarginsUSA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

USA does not have a ROIC to compare to the WACC, probably because it is not profitable.
USA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, USA has more shares outstanding
The debt/assets ratio for USA has been reduced compared to a year ago.
USA.CA Yearly Shares OutstandingUSA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
USA.CA Yearly Total Debt VS Total AssetsUSA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.53, we must say that USA is in the distress zone and has some risk of bankruptcy.
USA has a Altman-Z score of -1.53. This is comparable to the rest of the industry: USA outperforms 40.20% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that USA is not too dependend on debt financing.
USA has a Debt to Equity ratio of 0.23. This is in the lower half of the industry: USA underperforms 67.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -1.53
ROIC/WACCN/A
WACC8.62%
USA.CA Yearly LT Debt VS Equity VS FCFUSA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

USA has a Current Ratio of 0.52. This is a bad value and indicates that USA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.52, USA is not doing good in the industry: 67.99% of the companies in the same industry are doing better.
USA has a Quick Ratio of 0.52. This is a bad value and indicates that USA is not financially healthy enough and could expect problems in meeting its short term obligations.
USA's Quick ratio of 0.37 is on the low side compared to the rest of the industry. USA is outperformed by 69.85% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.37
USA.CA Yearly Current Assets VS Current LiabilitesUSA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

USA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.22%, which is quite impressive.
Looking at the last year, USA shows a quite strong growth in Revenue. The Revenue has grown by 19.88% in the last year.
Measured over the past years, USA shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%

3.2 Future

The Earnings Per Share is expected to grow by 27.34% on average over the next years. This is a very strong growth
USA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.17% yearly.
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue Next Year23.56%
Revenue Next 2Y35.98%
Revenue Next 3Y40.85%
Revenue Next 5Y31.17%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USA.CA Yearly Revenue VS EstimatesUSA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
USA.CA Yearly EPS VS EstimatesUSA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

USA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USA.CA Price Earnings VS Forward Price EarningsUSA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USA.CA Per share dataUSA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

USA's earnings are expected to grow with 27.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y27.16%

0

5. Dividend

5.1 Amount

USA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAS GOLD AND SILVER COR

TSX:USA (8/1/2025, 7:00:00 PM)

1.27

+0.01 (+0.79%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-18 2025-08-18
Inst Owners28.61%
Inst Owner ChangeN/A
Ins Owners24.03%
Ins Owner ChangeN/A
Market Cap828.50M
Analysts80
Price Target1.8 (41.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.78%
PT rev (3m)41.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-7.68%
Revenue NY rev (3m)-7.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.73
P/FCF N/A
P/OCF N/A
P/B 10.78
P/tB 10.78
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.22
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.23%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.7%
Cap/Sales 20.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.37
Altman-Z -1.53
F-Score5
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%
Revenue Next Year23.56%
Revenue Next 2Y35.98%
Revenue Next 3Y40.85%
Revenue Next 5Y31.17%
EBIT growth 1Y-0.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1732.34%
EBIT Next 3YN/A
EBIT Next 5Y146.33%
FCF growth 1Y-62.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-546.52%
OCF growth 3YN/A
OCF growth 5YN/A